Helen Blanco

Helén Johansen Blanco is Senior Clinical Director, Clinical Development at the Swedish biotech company Cantargia AB. She has 21+ years’ experience in clinical research and has worked within Big Pharma as AstraZeneca, the generic company Mylan, larger biotech as Celgene and in large and small CROs, in addition to several Scandinavian biotech companies. The majority of her career is within project/study management of phase I, II and III studies; with a track record of several leading registration trials within oncology, leading to successful marketed drug. Previously, she has worked and lived in Switzerland, Australia, Iceland, Sweden and Norway. Her passions are quality in clinical trials, proactive risk management and financial oversight.